The QUEST initiative: QUality of life Evaluation STudy: Assessing Health Related Quality of Life in patients receiving medicinal cannabis.

ittle Green Pharma Ltd.0 个研究点目标入组 2,804 人开始时间: 2021年1月27日最近更新: 2022年1月24日

试验速览

暂无简介。

•All of the following must be satisfied for enrolment in the study:
•adult patients (aged 18 years and over)
•patient has been identified as eligible to receive medicinal cannabis under the special access scheme (or equivalent in other countries and jurisdictions) by a doctor at participating centres registered to prescribe medicinal cannabis
•patient is able to read and understand English
•patient is able to provide informed consent
•patient has not started medicinal cannabis therapy, or the patient started medicinal cannabis therapy within the previous 2 days (we expect no therapeutic benefit within 2 days)
•patient has not received prescribed medicinal cannabis therapy in the previous 4 weeks (excluding previous 2 days)
•patient has a life-expectancy >3 months

•Patients will be excluded from the study if any of the following criteria apply:
•are unconscious or confused
•have cognitive impairment
•are pregnant
•are unable to speak, read and/or write in English
•are denied access to medicinal cannabis under the relevant Special Access Scheme for their country of registration
•are unable to provide informed consent
•are already receiving medicinal cannabis treatment for more than 2 days
•have received prescription medicinal cannabis within the last 4 weeks (excluding previous 2 days)

发起方

ittle Green Pharma Ltd.